{"title":"Relative to females, male rats are more willing to forego obtaining sucrose reward in order to prevent harm to their cage mate.","authors":"Evan M Hess, Marco Venniro, Todd D Gould","doi":"10.1007/s00213-023-06435-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Empathy, or the ability to perceive, share, and act upon the emotions of another, is a crucial social skill and is dysfunctional in autism and schizophrenia. While the complexities of human empathy are difficult to model in rodents, behavioral paradigms utilizing rats which study decision-making in social contexts may provide a translational framework for assessing biological, pharmacotherapeutic, and environmental interventions.</p><p><strong>Objectives: </strong>Modify and expand upon the three-session rat harm aversion task, which measures the willingness of rats to cease pressing a lever that earns them sucrose reward but delivers a shock to their cage mate. We sought to test the sustainability of harm aversion across seven sessions in male and female rats.</p><p><strong>Methods: </strong>Same-sex pair-housed rats were assigned as either the observer, which had access to the lever, or the demonstrator, which would receive shocks. After training the observer to press the lever to receive sucrose pellets, the demonstrator was placed into an adjacent chamber at which point lever responses would also deliver a shock. If the observer did not press the lever, no shock and no sucrose was delivered.</p><p><strong>Results: </strong>A sex difference in harm aversion was observed with female rats having significantly higher response rates and decreased response latencies across the seven test sessions, thus delivering more shocks and obtaining more sucrose, relative to males.</p><p><strong>Conclusions: </strong>These data demonstrate that male rats sustain harm aversion to a greater extent relative to females.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":"965-978"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-023-06435-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Empathy, or the ability to perceive, share, and act upon the emotions of another, is a crucial social skill and is dysfunctional in autism and schizophrenia. While the complexities of human empathy are difficult to model in rodents, behavioral paradigms utilizing rats which study decision-making in social contexts may provide a translational framework for assessing biological, pharmacotherapeutic, and environmental interventions.
Objectives: Modify and expand upon the three-session rat harm aversion task, which measures the willingness of rats to cease pressing a lever that earns them sucrose reward but delivers a shock to their cage mate. We sought to test the sustainability of harm aversion across seven sessions in male and female rats.
Methods: Same-sex pair-housed rats were assigned as either the observer, which had access to the lever, or the demonstrator, which would receive shocks. After training the observer to press the lever to receive sucrose pellets, the demonstrator was placed into an adjacent chamber at which point lever responses would also deliver a shock. If the observer did not press the lever, no shock and no sucrose was delivered.
Results: A sex difference in harm aversion was observed with female rats having significantly higher response rates and decreased response latencies across the seven test sessions, thus delivering more shocks and obtaining more sucrose, relative to males.
Conclusions: These data demonstrate that male rats sustain harm aversion to a greater extent relative to females.
期刊介绍：
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
